Effect of Double Dose of Alpha 1-antitrypsin Augmentation Therapy on Lung Inflammation.

This study is currently recruiting participants. (see Contacts and Locations)
Verified October 2014 by University of Miami
Sponsor:
Collaborator:
CSL Behring
Information provided by (Responsible Party):
Michael Campos, MD, University of Miami
ClinicalTrials.gov Identifier:
NCT01669421
First received: August 14, 2012
Last updated: October 13, 2014
Last verified: October 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2015
  Estimated Primary Completion Date: July 2015 (Final data collection date for primary outcome measure)